GABAkines–Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors

A Lippa, MM Poe, JL Smith, X Jin, X Ping… - Pharmacology & …, 2022 - Elsevier
Positive allosteric modulators of γ-aminobutyric acid-A (GABA A) receptors or GABAkines
have been widely used medicines for over 70 years for anxiety, epilepsy, sleep, and other …

Neuroinflammatory mediators in acquired epilepsy: an update

Y Chen, MM Nagib, N Yasmen, MN Sluter… - Inflammation …, 2023 - Springer
Epilepsy is a group of chronic neurological disorders that have diverse etiologies but are
commonly characterized by spontaneous seizures and behavioral comorbidities. Although …

High mobility group box-1 and blood–brain barrier disruption

M Nishibori, D Wang, D Ousaka, H Wake - Cells, 2020 - mdpi.com
Increasing evidence suggests that inflammatory responses are involved in the progression
of brain injuries induced by a diverse range of insults, including ischemia, hemorrhage …

[HTML][HTML] Astrocyte-neuron circuits in epilepsy

BS Purnell, M Alves, D Boison - Neurobiology of disease, 2023 - Elsevier
The epilepsies are a diverse spectrum of disease states characterized by spontaneous
seizures and associated comorbidities. Neuron-focused perspectives have yielded an array …

Neuroinflammation in epileptogenesis: from pathophysiology to therapeutic strategies

W Li, J Wu, Y Zeng, W Zheng - Frontiers in Immunology, 2023 - frontiersin.org
Epilepsy is a group of enduring neurological disorder characterized by spontaneous and
recurrent seizures with heterogeneous etiology, clinical expression, severity, and prognosis …

Ferrostatin-1 obviates seizures and associated cognitive deficits in ferric chloride-induced posttraumatic epilepsy via suppressing ferroptosis

KN Chen, QW Guan, XX Yin, ZJ Wang, HH Zhou… - Free Radical Biology …, 2022 - Elsevier
Posttraumatic epilepsy (PTE) is a prevalent complication of brain trauma. Current anti-
epileptic drugs available do not have satisfactory response to PTE. It is of desperate need to …

New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments

C Xu, Y Gong, Y Wang, Z Chen - Pharmacology & Therapeutics, 2022 - Elsevier
Epilepsy, one of the most severe neurological diseases, is characterized by abrupt recurrent
seizures. Despite great progress in the development of antiseizure drugs (ASDs) based on …

[HTML][HTML] The role of high mobility group box 1 in neuroinflammatory related diseases

J Mo, J Hu, X Cheng - Biomedicine & Pharmacotherapy, 2023 - Elsevier
High mobility group box 1 (HMGB1) is a ubiquitous and highly conserved non-histone DNA-
binding protein with different biological functions according to its subcellular localization. It is …

Neuroinflammation catching nanobubbles for microglia-neuron unit modulation against epilepsy

X Wang, Y Liu, M Li, Y Ju, J Tang, T Chen, X Lin, N Gu… - Biomaterials, 2023 - Elsevier
Epilepsy is a common neurological disease caused by synchronous firing of hyperexcitable
neurons. Currently, patients with epilepsy are typically treated with antiseizure medicines …

Deep brain stimulation in the medial septum attenuates temporal lobe epilepsy via entrainment of hippocampal theta rhythm

Y Wang, Y Shen, X Cai, J Yu, C Chen… - CNS neuroscience & …, 2021 - Wiley Online Library
Aims Temporal lobe epilepsy (TLE), often associated with cognitive impairment, is one of the
most common types of medically refractory epilepsy. Deep brain stimulation (DBS) shows …